Declare them worthless, without a trial. Finally, brand them as dangerous quackery. Systematized harassment pervades the eld of innovative cancer therapy. But there is another, more compelling, reason to do so. That is the fundamental question of human rights.
Patient autonomy is an essential part of democracy.
Since 1963, FDA has demanded a preponderance of medical opinion before allowing a new drug to be marketed. This can take decades and millions of dollars. By applying this unreasonable standard, FDA systematically limits a cancer patient s free choice. Unanimity of opinion in medicine is rare. History provides many examples of tragic errors shared by a preponderance of experts.